News

News

Press Release

Human Longevity, Inc. Announces Agreement with Merck KGaA, Darmstadt, Germany to Engage in Cancer Biomarker Discovery in Advanced Melanoma

(SAN DIEGO, CA)—June 15, 2017—Human Longevity, Inc. (HLI), the genomics-powered, health intelligence company, announced today that the company has signed an agreement with Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, with the goal of pioneering the application of advanced genomics and expert analysis with machine learning to transform drug development and medical use of next generation therapeutics.

Continue Reading
Press Releases

Human Longevity, Inc. Announces Agreement with Merck KGaA, Darmstadt, Germany to Engage in Cancer Biomarker Discovery in Advanced Melanoma

(SAN DIEGO, CA)—June 15, 2017—Human Longevity, Inc. (HLI), the genomics-powered, health intelligence company, announced today that the company has signed an agreement with Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, with the goal of pioneering the application of advanced genomics and expert analysis with machine […]

Continue Reading
Press Releases

Saturnino (Nino) Fanlo Joins Human Longevity, Inc. as Chief Financial Officer

Financial Industry Leader Brings 30 Years of Experience Leading Public, Private Companies; Raising Billions in Financing Rounds (SAN DIEGO, CA)—May 25, 2017—Human Longevity, Inc. (HLI), the genomics-based, health intelligence company, announced today that Saturnino (Nino) Fanlo will be joining the company as Chief Financial Officer, reporting to CEO Cynthia Collins. Fanlo brings decades of financial […]

Continue Reading
Press Releases

Human Longevity, Inc. Launches Pilot Program, Health Nucleus X

Offering Includes Whole Genome Sequencing and Full Body MRI to Give Insight into Cancer, Cardiovascular, Metabolic and Neurological Disease Risk (SAN DIEGO, CA)—May 11, 2017—Human Longevity, Inc. (HLI), the genomics-based, health intelligence company, today announced a pilot program, Health Nucleus X (HNX) as part of the company’s Health Nucleus clinical research program, that offers individuals […]

Continue Reading
Press Releases

Human Longevity, Inc. Enhances Senior Leadership Team, Making Key Hires to Strengthen Commercialization and Operations

Travis Lacey is Chief Corporate Development Officer, Dale Gordon is Chief Commercialization Officer, Gary G. Altman, Ph.D., joins as Chief Operating Officer and Steven Ness, D.O., is Head of Client Services (SAN DIEGO, CA) May 2, 2017– Human Longevity, Inc. (HLI) the genomics-powered, health intelligence company, announced today that several new senior staff have been […]

Continue Reading
Partner Releases

The Worth Group Unveils First Health and Wellness Summit

Selects San Diego as Host Location, Announces Partnership with Human Longevity Inc. (HLI)

Continue Reading
Press Releases

Machine Learning Visionary, David Heckerman, Joins Human Longevity, Inc. as Chief Data Scientist

SAN DIEGO, CA, March 21, 2017 – Human Longevity, Inc., the genomics–powered, health intelligence company, announced today that David Heckerman, M.D., PhD., a 25-year veteran of Microsoft, has joined the company as the Chief Data Scientist. Dr. Heckerman, who will report to J. Craig Venter, Ph.D., HLI Co-founder, Executive Chairman and head of scientific strategy, […]

Continue Reading
Press Releases

Human Longevity, Inc. and MassMutual Sign Groundbreaking Agreement to Offer HLIQ™ Whole Genome Sequencing to MassMutual’s Customers, Financial Professionals and Employees

SAN DIEGO, Calif. and SPRINGFIELD, Mass. – March 15, 2017— Human Longevity, Inc. (HLI), the genomics-based, health intelligence company and Massachusetts Mutual Life Insurance Co. (MassMutual), announced today they have signed an innovative multi-year agreement to offer HLI’s whole genome sequencing product, HLIQ Whole Genome, to eligible MassMutual customers, employees and financial professionals at a […]

Continue Reading
Press Releases

In Largest Whole Genome Sequence Analysis Study, Human Longevity, Inc.-Led Team Identifies Common-to-Rare Variants in the Human Blood Metabolome

The study shows the power of whole genome sequencing and analysis to uncover new variants missed in exome or genotyping arrays (SAN DIEGO, CA)—March 6, 2017—Researchers from Human Longevity, Inc. (HLI), the genomics-based, health intelligence company, have published results from the largest whole genome sequencing and analysis of blood metabolites. They were able to link […]

Continue Reading
Press Releases

Human Longevity, Inc. Hires Cynthia Collins, Healthcare Industry Leader, as New Chief Executive Officer

Craig Venter, Ph.D., Co-founder and former CEO, will remain at Company as Executive Chairman and continue in full time role guiding scientific vision and strategy (SAN DIEGO, CA)—January 4, 2017—Human Longevity, Inc. (HLI), the genomics-driven, health intelligence company, today announced Cynthia Collins as the new Chief Executive Officer effective January 9, 2017. Collins, who has […]

Continue Reading
News Alerts

Embracing the Perks of Cloud Computing

By Yaron Turpaz, Ph.D., MBA, CIO, Human Longevity, Inc. Human Longevity, Inc. was launched in March 2014 with a mission to transform healthcare and accelerate the practice of personalized, preventive healthcare via detailed and comprehensive genomics analysis and risks assessment, in integration with high quality phenotypic and medical information. We have built the largest human […]

Continue Reading

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets